EQS-News: M1 Kliniken AG: Capital reduction through cancellation of treasury shares successfully completed
|
EQS-News: M1 Kliniken AG
/ Key word(s): Corporate Action
M1 Kliniken AG: Capital reduction through cancellation of treasury shares successfully completed Berlin, 26 May 2026 – M1 Kliniken AG (ISIN DE000A0STSQ8) has cancelled the treasury shares acquired under its share buyback programme and reduced its share capital accordingly. On 25 March 2026, the Management Board resolved, with the approval of the Supervisory Board granted on 26 March 2026 and on the basis of the authorisation by the Annual General Meeting of 17 July 2024, to reduce the Company's share capital by EUR 1,088,289 from EUR 19,643,403 to EUR 18,555,114. The capital reduction became effective upon registration in the commercial register of the Local Court of Charlottenburg (HRB 107637 B) on 26 May 2026. The cancellation was carried out under the simplified procedure pursuant to Section 237 (3) no. 3 of the German Stock Corporation Act (AktG). The Articles of Association were amended accordingly in Section II. 4. (Amount and Division of the Share Capital). About M1 Kliniken AG M1 Kliniken AG is the leading fully integrated provider of medical aesthetic services in Europe and Australia. With a clear strategic focus, high standardisation, and consistent scalability, the Group currently operates 59 clinics in ten countries under the M1 Med Beauty brand. All treatments are performed exclusively by qualified physicians and adhere to uniform, high medical standards, while being offered at market-leading prices. Since late 2018, M1 has systematically driven its international expansion, which forms the basis for scalable future growth and the further development of its global market position. With the M1 Schlossklinik in Berlin, the Group operates one of Europe’s largest and most modern clinics for plastic and aesthetic surgery, featuring four operating theatres and 35 beds.
Grünauer Straße 5 12557 Berlin T: +49 (0)30 347 47 44 14 M: ir@m1-kliniken.de
26.05.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | M1 Kliniken AG |
| Grünauer Straße 5 | |
| 12557 Berlin | |
| Germany | |
| Phone: | +49 (0)30 347 47 44 14 |
| Fax: | +49 (0)30 347 47 44 17 |
| E-mail: | ir@m1-kliniken.de |
| Internet: | https://www.m1-kliniken.de |
| ISIN: | DE000A0STSQ8 |
| WKN: | A0STSQ |
| Listed: | Regulated Unofficial Market in Dusseldorf, Frankfurt (Basic Board), Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX |
| EQS News ID: | 2333736 |
| End of News | EQS News Service |
|
|
2333736 26.05.2026 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | ||
| Sales1 | 159,59 | 314,61 | 285,29 | 316,32 | 339,18 | 364,30 | 135,00 | |
| EBITDA1,2 | 8,89 | 17,82 | 15,41 | 21,01 | 31,96 | 39,44 | 36,00 | |
| EBITDA-Margin3 | 5,57 | 5,66 | 5,40 | 6,64 | 9,42 | 10,83 | 26,67 | |
| EBIT1,4 | 4,41 | 12,13 | 9,35 | 15,70 | 26,75 | 34,56 | 32,00 | |
| EBIT-Margin5 | 2,76 | 3,86 | 3,28 | 4,96 | 7,89 | 9,49 | 23,70 | |
| Net Profit (Loss)1 | 7,43 | 10,88 | 7,07 | 11,67 | 17,79 | 24,10 | 25,00 | |
| Net-Margin6 | 4,66 | 3,46 | 2,48 | 3,69 | 5,25 | 6,62 | 18,52 | |
| Cashflow1,7 | 9,54 | 15,68 | 20,77 | 7,81 | 30,55 | 37,95 | 39,00 | |
| Earnings per share8 | 0,37 | 0,45 | 0,22 | 0,54 | 0,85 | 1,19 | 1,24 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,50 | 0,50 | 1,20 | 0,60 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: wetreu NTRG
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| M1 Kliniken | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A0STSQ | DE000A0STSQ8 | AG | 352,55 Mio € | 14.09.2015 | Kaufen | 9F4MCHV9+6R |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 13,97 | 25,31 | 0,55 | 30,70 | 3,61 | 9,29 | 0,97 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,50 | 0,50 | 1,20 | 6,32% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 08.07.2026 | 03.06.2026 | 09.09.2026 | 18.11.2026 | 20.05.2026 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +16,79% | +19,29% | +0,00% | +34,18% | +304,26% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
